Sanara MedTech Inc.

NASDAQ:SMTI

Medical - Instruments & Supplies

Healthcare
$32.73 +3.44%

+$0.73 today

Market cap
$300.55M
Beta
1.19
P/E (TTM)
-5.7
EPS (TTM)
-$3.86
52W Low $16.05High $35.95

Volume 0.07M

Average 0.06M

SMTI Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

Sanara MedTech Inc.NASDAQ: SMTI

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables turns negative

Q1 FY2026 accounts payables was -$1.42M, compared with $606.73K a year earlier. Trailing-twelve-month accounts payables was -$781.12K.

Context

  • Accounts payables amounted to 1.2% of revenue in FY2025, up 0.7 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near -$1.42M or moves back toward the trailing-twelve-month quarterly average of -$195.28K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.42M-247.8% QoQ
Last fiscal yearDec 2025
$1.24M+363.8% YoY
LTMMar 2026
-$781.12K-162.9% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-333.6%——
1 year+363.8%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
1.24M USD
Year-over-year change
+363.8%
4-year CAGR
+88.2%

Accounts Payables vs competitors

How SMTI compares with its peers on the latest reported figures

  • Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -162.9% is the 7th highest of 10, against a peer median of -56.4%.
  • Accounts payables amounts to 0.7% of revenue for SMTI, versus a peer median of 2.2%.
SMTI Competitors
Accounts Payables for SMTI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NEONeoGenomics, Inc.LTM Jun 2026$16.49M USD-289.5%—2.2%
LFMDLifeMD, Inc.LTM Mar 2026$11.08M USD+237.4%+37.4%5.0%
TBRGTruBridge, Inc.LTM Mar 2026$7.61M USD+175.5%—2.2%
STXSStereotaxis, Inc.LTM Mar 2026$1.78M USD-219.3%+73.3%5.7%
SGHTSight Sciences, Inc.LTM Mar 2026$1.28M USD-223.1%-20.6%1.6%
VMDViemed Healthcare, Inc.LTM Mar 2026$885K USD+342.5%—0.3%
SMTISanara MedTech Inc.LTM Mar 2026$781.12K USD-162.9%—0.7%
TRDAEntrada Therapeutics, Inc.LTM Mar 2026$752K USD+384.8%—13.1%
HITIHigh Tide Inc.LTM Apr 2026CA$283K CAD-56.4%—0.0%
XGNExagen Inc.LTM Mar 2026$230K USD-110.5%-64.0%0.3%
Peer median (excluding SMTI) —-56.4%+8.4%2.2%

Competitors are the stored peer set for SMTI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(7.99M)(8.09M)(4.44M)(9.91M)(27.66M)
Depreciation & Amortization596.98K2.37M3.68M4.92M28.56M
Deferred Income Tax0(5.84M)000
Stock-Based Compensation2.67M2.7M3.44M4.44M718.71K
Change in Working Capital(1.18M)517.62K(3.28M)(911.72K)(3.84M)
Accounts Receivables(774.81K)(2.27M)(1.73M)(4.54M)4.03M
Inventory(1.15M)(517.27K)(1.55M)1.44M(431.33K)
Accounts Payables99.13K(423.75K)575.15K(471.21K)1.24M
Other Working Capital645.56K3.73M(577.32K)2.66M(8.68M)
Other Non-Cash Items1.1M2.79M(2.64M)1.44M9.02M
Operating Cash Flow(4.81M)(5.55M)(3.25M)(23.78K)6.79M
Capital Expenditures(750.45K)(747.02K)(265.25K)(229.3K)(4.63M)
Acquisitions (Net)0(2.52M)(9.94M)00
Purchases of Investments(4.53M)(250K)0(5.3M)9.48M
Sales of Investments0000(2.96M)
Other Investing Activities(578.59K)(598.45K)650(1.1M)(10.47M)
Investing Cash Flow(5.28M)(3.51M)(10.21M)(6.61M)(8.36M)
Debt Repayment009.69M19.59M0
Common Stock Issued28.94M0911.37K00
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(642.53K)(627.35K)(958.59K)(2.15M)(8.48M)
Financing Cash Flow28.3M(627.35K)9.64M17.37M(8.48M)
Effect of Forex Changes00000
Net Change in Cash18.2M(9.69M)(3.81M)10.73M(10.03M)
Free Cash Flow(5.56M)(6.3M)(3.51M)(253.08K)2.16M

Sanara MedTech Inc.

NASDAQ:SMTI

Intrinsic Alpha fair value

Locked

Current Price

$32.73

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.